Congress Is ‘Too Scared’ of the AMA to Really Attack Opioids
As the opioid epidemic ravages the country, lawmakers pushing for reforms to how the drugs are prescribed have encountered a series of roadblocks from a surprising source: the lobby for physicians.
Advocates for further restrictions and physician education on the highly addictive drugs say the American Medical Association has actively lobbied against the inclusion of several recommendations by the Centers for Disease Control and Prevention and that many members of Congress are unwilling to go up against the powerful lobby.
Several of the CDC guidelines were included in a bill called Comprehensive Addiction & Recovery Act 2.0, introduced by Sen. Rob Portman (R-OH) and Sen. Sheldon Whitehouse (D-RI) in February, an update to the Comprehensive Addiction & Recovery Act that was signed into law in 2016.Portman’s office confirmed that lobbyists from the group have told the Ohio senator’s staff they would not support provisions in the CARA 2.0 about the three-day rule or any mandatory physician education included in the bill.
The AMA opposition to proposals like limiting prescriptions of the highly addictive drugs to three-day supplies, mandating that physicians have courses about drugs and addiction, or even requiring physicians to check databases before prescribing certain drugs has confused and infuriated advocates.
During a meeting of advocates to curb opioid abuse last week, Sen. Joe Manchin (D-WV) summed up the lack of progress on certain proposals, telling the group that some of his colleagues were “too scared to take on the AMA.”
The AMA was the seventh highest lobbying spender in 2017, with $21.5 million spent. Nearly $6.8 million has been spent in 2018 so far, according to OpenSecrets.com. It gave nearly $2 million to members of Congress in 2016 and has given $519,500 so far this election cycle.